Zhuowei Luo | Pharmacology, Toxicology and Pharmaceutical Science | Research Excellence Award

Published on by Book of Award

Mr. Zhuowei Luo | Pharmacology, Toxicology and Pharmaceutical Science | Research Excellence Award

Hubei University of Chinese Medicine | China

Mr. Zhuowei Luo is an emerging researcher recognized for effectively integrating classical Traditional Chinese Medicine (TCM) theory with modern biomedical science, demonstrating strong expertise in molecular mechanism analysis and advanced metabolomics for chronic disease research. His notable scientific contribution is a co-authored publication in the Journal of Ethnopharmacology (Q2, IF 5.14), where he helped elucidate how Allium macrostemon delays chronic renal failure by modulating the IL-17 signaling pathway and altering tryptophan and glycerophospholipid metabolism. This work represents the first comprehensive study connecting immunological regulation with multi-omics profiling to explain the therapeutic mechanisms of this TCM herb, providing a meaningful model for modernizing traditional medicine through systems biology. His role in the project included designing and validating qPCR primers, conducting network pharmacology to identify key molecular targets, performing metabolomics and transcriptomics data analyses, and carrying out histopathological assessments. Through these contributions, he demonstrated an advanced ability to apply interdisciplinary approaches—combining immunology, pharmacology, and bioinformatics—to uncover mechanistic insights into natural product–based interventions. His research reflects scientific maturity beyond typical early-stage experience and contributes to the growing evidence supporting data-driven modernization of TCM in chronic disease treatment.

Profile : Orcid

Featured Publication

Zhao, Y., Ge, J. X., Zhang, N., Lei, Z. X., Sun, S. Y., Luo, Z. W., Yang, Y. F., & Wu, H. Z. (2025). Allium macrostemon Bge. delays chronic renal failure by modulating IL-17 signaling pathway and affecting tryptophan/glycerophospholipid metabolism. Journal of Ethnopharmacology, 120946.

Annalisa Bosi | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Book of Award

Dr. Annalisa Bosi | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

University of Insubria | Italy

Dr. Annalisa Bosi is a distinguished researcher with 909 citations, 29 scientific documents, and an h-index of 15, reflecting her strong impact in the fields of immunology, gastrointestinal pathology, and microbiota–gut–brain axis research. Her early work focused on the phenotypic and functional characterization of innate immune components, particularly NK cells and macrophages, examining their role in tumor pathogenesis and their modulation by chemotherapeutic agents or plant-derived molecules. She later advanced her research to explore molecular and cellular mechanisms underlying major gastrointestinal diseases such as ischemia, intestinal inflammation, and enteric neuropathy, identifying the regulatory role of hyaluronic acid homeostasis in tissue repair. Her recent studies investigate gut microbiota, dysbiosis, and their influence on neurodevelopment and tumor etiopathogenesis, with growing emphasis on prebiotic and probiotic interventions. Dr. Bosi has contributed significantly to understanding experimental models of gut pathology, neuromuscular dysfunction, immunomodulation by virome components, and sex-dependent microbial effects. Her publications span high-impact journals, covering topics such as microbiota–immune interactions, ischemia–reperfusion injury, cytokine–phage crosstalk, and neuroimmune modulation. Through multidisciplinary approaches integrating molecular biology, immunology, and neurogastroenterology, her work continues to shape emerging perspectives on host–microbiota communication and its relevance to disease mechanisms and therapeutic strategies.

Profiles : Scopus | Orcid

Featured Publications

Bosi, A., Baranzini, N., Ponti, A., Moretto, P., Moro, E., Crema, F., Cianci, R., Karousou, E., Viola, M., Passi, A., et al. (2025). Intestinal ischemia/reperfusion injury influences hyaluronan homeostasis in the rat brain. International Journal of Molecular Sciences, 26(20), 10064.

Cianci, R., Caldarelli, M., Brani, P., Bosi, A., Ponti, A., Giaroni, C., & Baj, A. (2025). Cytokines meet phages: A revolutionary pathway to modulating immunity and microbial balance. Biomedicines, 13(5), 1202.

Faggin, S., Cerantola, S., Caputi, V., Tietto, A., Stocco, E., Bosi, A., Ponti, A., Bertazzo, A., Macchi, V., Porzionato, A., et al. (2025). Toll-like receptor 4 deficiency ameliorates experimental ileitis and enteric neuropathy: Involvement of nitrergic and 5-hydroxytryptaminergic neurotransmission. British Journal of Pharmacology, 182(8), 1803–1822.

Brani, P., Manzoor, H. Z., Spezia, P. G., Vigezzi, A., Ietto, G., Dalla Gasperina, D., Minosse, C., Bosi, A., Giaroni, C., Carcano, G., et al. (2025). Torque Teno Virus: Lights and shades. Viruses, 17(3), 334.

Dal Lago, S., Brani, P., Ietto, G., Dalla Gasperina, D., Gianfagna, F., Giaroni, C., Bosi, A., Drago Ferrante, F., Genoni, A., Manzoor, H. Z., et al. (2024). Torque Teno Virus: A promising biomarker in kidney transplant recipients. International Journal of Molecular Sciences, 25(14), 7744.

Giambra, V., Pagliari, D., Rio, P., Totti, B., Di Nunzio, C., Bosi, A., Giaroni, C., Gasbarrini, A., Gambassi, G., & Cianci, R. (2023). Gut microbiota, inflammatory bowel disease, and cancer: The role of guardians of innate immunity. Cells, 12(22), 2654.

Bosi, A., Banfi, D., Bistoletti, M., Catizzone, L. M., Chiaravalli, A. M., Moretto, P., Moro, E., Karousou, E., Viola, M., Giron, M. C., et al. (2022). Hyaluronan regulates neuronal and immune function in the rat small intestine and colonic microbiota after ischemic/reperfusion injury. Cells, 11(21), 3370.

Bosi, A., Banfi, D., Bistoletti, M., Moretto, P., Moro, E., Crema, F., Maggi, F., Karousou, E., Viola, M., Passi, A., et al. (2021). Hyaluronan: A neuroimmune modulator in the microbiota–gut axis. Cells, 11(1), 126.

Cerantola, S., Caputi, V., Contarini, G., Mereu, M., Bertazzo, A., Bosi, A., Banfi, D., Mantini, D., Giaroni, C., & Giron, M. C. (2021). Dopamine transporter genetic reduction induces morpho-functional changes in the enteric nervous system. Biomedicines, 9(5), 465.

Banfi, D., Moro, E., Bosi, A., Bistoletti, M., Cerantola, S., Crema, F., Maggi, F., Giron, M. C., Giaroni, C., & Baj, A. (2021). Impact of microbial metabolites on microbiota–gut–brain axis in inflammatory bowel disease. International Journal of Molecular Sciences, 22(4), 1623.

Baci, D., Bosi, A., Parisi, L., Buono, G., Mortara, L., Ambrosio, G., & Bruno, A. (2020). Innate immunity effector cells as inflammatory drivers of cardiac fibrosis. International Journal of Molecular Sciences, 21(19), 7165.

Baci, D., Bosi, A., Gallazzi, M., Rizzi, M., Noonan, D. M., Poggi, A., Bruno, A., & Mortara, L. (2020). The ovarian cancer tumor immune microenvironment (TIME) as target for therapy: A focus on innate immunity cells as therapeutic effectors. International Journal of Molecular Sciences, 21(9), 3125.

Bosi, A., Banfi, D., Bistoletti, M., Giaroni, C., & Baj, A. (2020). Tryptophan metabolites along the microbiota–gut–brain axis: An interkingdom communication system influencing the gut in health and disease. International Journal of Tryptophan Research, 13, 1–18.

Keon-Hyoung Song | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Book of Award

Prof. Dr. Keon-Hyoung Song | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Soonchunhyang University | South Korea

Prof. Dr. Keon-Hyoung Song is a distinguished researcher whose work bridges pharmaceutical sciences, drug delivery systems, and pharmacokinetics. With 708 citations, 27 scholarly publications, and an h-index of 13, his research has significantly advanced the understanding of membrane permeation enhancers, drug formulation, and solubilization strategies. His extensive portfolio includes high-impact studies on intestinal absorption mechanisms, cocrystal engineering, and pharmacokinetic optimization, published in reputed journals such as Pharmaceutics, European Journal of Medicinal Chemistry, and Journal of Controlled Release. Prof. Song’s innovations extend beyond academia, with over 25 international patents registered across the U.S., Europe, and Korea, focusing on permeation-enhancing peptides, liposomal carriers, and pharmaceutical formulations. His pioneering patents, including those on mucous membrane permeation peptides (EP 3875103, 2025) and sugar alcohol-based liposome compositions, underscore his role in translating laboratory discoveries into therapeutic applications. Licensed as both a Patent Attorney and a Pharmacist, he effectively integrates regulatory insight with scientific innovation. Prof. Song’s sustained contributions to quantitative drug analysis using LC-MS and formulation optimization have made him a leading figure in advancing next-generation drug delivery technologies and pharmaceutical development.

Profile : Scopus

Featured Publications

Jeong, D.-H., Kim, J.-W., & Song, K.-H. (2025). Improved intestinal permeation of cyclosporin A by FCIGRL-modified tight junction modulator in rats. Pharmaceutics, 17(11), 1395.

Park, G., Galdamez, A., Song, K.-H., Le, M., Kim, K., & Lin, J. H. (2024). Ethnic variation and structure–function analysis of tauopathy-associated PERK alleles. Israel Journal of Chemistry, 64(12).

Song, K.-H. (2024). Effect of tight junction-modulating FCIGRL-modified peptides on the intestinal absorption of doxorubicin in rats. Pharmaceutics, 16(5), 650.

Jiang, F.-L., Jeong, D.-H., Eom, S.-H., Lee, H.-M., Cha, B.-J., Park, J.-S., Kwon, R.-K., Nam, J.-Y., Yu, H.-S., Heo, S.-H., Kim, C.-H., & Song, K.-H. (2024). Effects of enteric-coated formulation of sodium bicarbonate on bicarbonate absorption and gastrointestinal discomfort. Nutrients, 16(5), 744.

Koo, N. R., Yoon, S., Song, K.-H., Baek, M. J., Jeon, S., & Im, J. (2024). Tumor-homing peptide iRGD-conjugate enhances tumor accumulation of camptothecin for colon cancer therapy. European Journal of Medicinal Chemistry, 265, 116050.

Park, G., Xu, K., Chea, L., Kim, K., Safarta, L., Song, K.-H., Wu, J., Park, S., Min, H., Hiramatsu, N., Han, J., & Lin, J. H. (2023). Neurodegeneration risk factor EIF2AK3 (PERK) influences tau protein aggregation. The Journal of Biological Chemistry, 299(2), 102821.

Eom, Y. S., Jeong, D., Ryu, A.-R., Song, K.-H., Im, D. S., & Lee, M.-Y. (2022). Daphne odora exerts depigmenting effects via inhibiting CREB/MITF and activating AKT/ERK-signaling pathways. Current Issues in Molecular Biology, 44(8), 3312–3323.

Kim, H., Song, K.-H., Ambegaonkar, J. P., Chung, S., Jeon, K., Jiang, F. L., Eom, J. J., & Kim, C.-H. (2022). Two-megahertz impedance index prediction equation for appendicular lean mass in Korean older people. BMC Geriatrics, 22(1), 385.

Jiang, F., Tang, S., Eom, J.-J., Song, K.-H., Kim, H., Chung, S., & Kim, C.-H. (2022). Accuracy of estimated bioimpedance parameters with octapolar segmental bioimpedance analysis. Sensors, 22(7), 2681.

Yoon, Y. M., Lee, J. H., Song, K.-H., Noh, H., & Lee, S. H. (2020). Melatonin-stimulated exosomes enhance the regenerative potential of chronic kidney disease-derived mesenchymal stem/stromal cells via cellular prion proteins. Journal of Pineal Research, 68(3), e12632.

Lee, J. H., Yoon, Y. M., Song, K.-H., Noh, H., & Lee, S. H. (2020). Melatonin suppresses senescence-derived mitochondrial dysfunction in mesenchymal stem cells via the HSPA1L-mitophagy pathway. Aging Cell, 19(3), e13111.

Cha, S. J., Choi, H.-J., Kim, H.-J., Choi, E. J., Song, K.-H., Im, D. S., & Kim, K. (2020). Parkin expression reverses mitochondrial dysfunction in fused in sarcoma-induced amyotrophic lateral sclerosis. Insect Molecular Biology, 29(1), 56–65.*

Hemantkumar Akolkar | Chemistry | Best Researcher Award

Published on by Book of Award

Assoc. Prof. Dr. Hemantkumar Akolkar | Chemistry | Best Researcher Award

Rayat Shikshan Sanstha’s Abasaheb Marathe Arts and New Commerce, Science College | India

Assoc. Prof. Dr. Hemantkumar Akolkar is a distinguished academic and researcher in the field of chemistry with over 15 years of teaching and research experience. He earned his Ph.D. in Chemistry from Radhabai Kale Mahila Mahavidyalaya, affiliated with Savitribai Phule Pune University, and has since contributed significantly to the advancement of heterocyclic and green chemistry. His prolific research career includes 66 publications in reputed international journals, with an h-index of 7, i10-index of 4, and 284 citations, reflecting the growing impact of his work. Dr. Akolkar has successfully completed funded research projects from UGC and BCUD and holds six granted Indian patents on novel heterocyclic compounds with therapeutic and industrial potential. He has authored seven books and nine book chapters with leading publishers such as Springer, IGI Global, and the Royal Society of Chemistry, further highlighting his academic contributions. Additionally, he has presented 17 research papers at national and international conferences, organized academic events, and serves as a reviewer for renowned international journals including Scientific Reports and ChemistrySelect. Recognized as a Ph.D. guide and PG teacher by multiple universities, his work bridges innovation, pedagogy, and research leadership, making him a highly respected figure in chemical sciences.

Profiles : Scopus | Orcid | Google Scholar

Featured Publications

"Eco-Friendly Fabrication of Silver Nanoparticles Using Syzygium stocksii Leaf Extract: Physicochemical Characterization and Evaluation of Antioxidant and Anti-Inflammatory Activities"

"Synthesis, Antimicrobial Activity, and Molecular Docking Study of Novel (E)-1-(5-Chloro-2-hydroxyphenyl)-3-{5-fluoro-2-[(1-phenyl-1 H-1, 2, 3-triazol-4-yl) methoxy] phenyl}-prop-2-en-1-one Derivatives"

"Synthesis and Antimicrobial Evaluation of (E)-1-(2, 4-Dichlorophenyl)-4-{3-methoxy-4-[(1-phenyl-1 H-1, 2, 3-triazol-4-yl) methoxy] benzylidene}-3-methyl-1 H-pyrazol-5 (4 H)-one Derivatives"

"Optimizing Parthenium waste: biomass-derived carbon adsorbents for adsorbing Amido Black 10B dye analyzed through graph theory for stability and reactivity"

"Synthesis and Antimicrobial Evaluation of (E)-2-(4-((4-((1-(2, 4-Dichlorophenyl)-3-methyl-5-oxo-1, 5-dihydro-4 H-pyrazol-4-ylidene) methyl)-2-methoxyphenoxy) methyl)-1 H-1, 2, 3-triazol-1-yl)-N-phenylacetamide Derivatives"

"Eco-friendly development of Leucas aspera-derived MoO3 nanoparticles: corrosion studies and multifunctional applications in medicine, agriculture, and industry"

"Optimized green synthesis of biocompatible Ag nanostructures using Artemisia Indica leaf extract: a promising avenue for biomedical applications"

"Facile and Proficient Synthesis of Some New 1,2,4-Triazole-3-Thiones Derivatives Using [H2-TMDP][HPO4] Ionic Liquid"

"Synthesis, Antimicrobial Evaluation, and Computational Study of Novel Fluorinated Benzofuran Derivatives"

"New 1, 2, 3‐Triazole‐Tethered Chalcone Derivatives: Synthesis, Bioevaluation and Computational Study"

"Design, Synthesis, Molecular Docking, and Anti-inflammatory Activity of 2-[(E)-{1-[4-(4-Chlorophenyl)-1, 3-thiazol-2-yl]-1H-pyrazol-4-yl}(hydroxyimino) methyl] phenol and {1-[4-(4-Chlorophenyl)-1, 3-thiazol-2-yl]-1H-pyrazol-4-yl}(2-hydroxyphenyl) methanone Derivatives"

John Matsoukas | Chemistry | Excellence in Innovation Award

Published on by Book of Award

Prof. John Matsoukas | Chemistry | Excellence in Innovation Award

University of Patras | Greece

Professor John Matsoukas is a distinguished scholar in the field of chemistry and drug discovery, with over four decades of academic and research contributions spanning peptide chemistry, medicinal chemistry, and rational drug design. He has served as Professor of Chemistry at the University of Patras since 1995 and has held multiple visiting and adjunct appointments internationally, reflecting his global academic influence. His pioneering work in the design of non-peptide mimetics for peptide hormones and immune-related targets has significantly advanced research in hypertension, cancer, multiple sclerosis, and antiviral therapeutics. A prolific author, he has published 189 peer-reviewed papers, 50 book chapters, and numerous conference proceedings, bringing his total scholarly outputs to more than 600. His research has been widely recognized, accumulating over 5,500 citations and an h-index of 42, underscoring both productivity and impact within the scientific community. In addition, his innovative contributions are reflected in multiple patents, editorial roles, and his leadership in founding the Graduate Program in Medicinal Chemistry: Drug Discovery and Design, the first Euromaster-awarded program in Greece. Beyond academia, he has also established spin-offs and startups, securing over €15 million in grants, and continues to shape international biomedical networks, cementing his legacy as a leading figure in drug discovery and medicinal chemistry.

Profile : Scopus | Orcid

Featured Publications

"Docking Simulations of G-Protein Coupled Receptors Uncover Crossover Binding Patterns of Diverse Ligands to Angiotensin, Alpha-Adrenergic and Opioid Receptors: Implications for Cardiovascular Disease and Addiction"

"Gating Mechanism for Biased Agonism at Angiotensin II Type 1 Receptors"

"Semi-Supervised Learning for Predicting Multiple Sclerosis"

"Computational Evidence for Bisartan Arginine Blockers as Next-Generation Pan-Antiviral Therapeutics Targeting SARS-CoV-2, Influenza, and Respiratory Syncytial Viruses"

"A methamphetamine vaccine using short monoamine and diamine peptide linkers and poly-mannose"

"Density functional theory and enzyme studies support interactions between angiotensin receptor blockers and angiotensin converting enzyme-2: Relevance to coronavirus 2019"

"Myelin Oligodendrocyte Glycoprotein (MOG)35–55 Mannan Conjugate Induces Human T-Cell Tolerance and Can Be Used as a Personalized Therapy for Multiple Sclerosis"

"Structural Features Influencing the Bioactive Conformation of Angiotensin II and Angiotensin A: Relationship between Receptor Desensitization, Addiction, and the Blood–Brain Barrier"

Masroor Badshah | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Book of Award

Dr. Masroor Badshah | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Monash University | Australia

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits

Dr. Masroor Badshah’s academic foundation is marked by a rigorous pursuit of medicine and anatomical sciences. Beginning with his degree in Medicine and Surgery, he developed an early research interest in the clinical relevance of anatomy, completing projects on skin diseases and vascular variations. His postgraduate studies at the University of Dundee expanded his expertise into human anatomy, where he defended a dissertation on carotid artery variations. This path led him to Monash University, where he earned his doctorate in medicine, focusing on oxytocin signaling in regulating the myogenic tone of the prostate and bladder. These early endeavors established a solid base for his later contributions to pharmacology and biomedical sciences.

Professional Endeavors

Dr. Badshah’s professional journey spans multiple countries, reflecting both versatility and international recognition. He began his teaching career as a lecturer and assistant professor in human anatomy at medical institutions in Pakistan before moving to Scotland and later Australia. His teaching associate roles at Monash University and research assistantship at the Monash Institute of Pharmaceutical Sciences allowed him to mentor students, design innovative teaching methodologies, and participate in collaborative research. His clinical internships in medicine and surgery also provided him with practical exposure that enriched his academic and research perspectives.

Contributions and Research Focus

At the core of Dr. Badshah’s career lies his dedication to advancing knowledge in pharmacology, toxicology, and pharmaceutical sciences. His doctoral work investigated the pharmacological role of oxytocin receptor antagonists in bladder and prostate function, with implications for overactive bladder treatments. His broader research includes studies in human surface anatomy, craniofacial asymmetry, morphometry of skeletal structures, and the clinical relevance of anatomical variations. By combining anatomical precision with pharmacological inquiry, he bridges the gap between foundational science and therapeutic application.

Accolades and Recognition

Throughout his career, Dr. Badshah has been honored with prestigious awards and scholarships, including the Monash Graduate Scholarship, Faculty International Tuition Scholarship, and the University of Dundee Tuition Scholarship. His academic excellence is reflected in multiple publications in peer-reviewed journals such as Biomedicines, Clinical Anatomy, and the Italian Journal of Anatomy and Embryology. He has also been a frequent presenter at international conferences, where his research findings on oxytocin signaling and anatomical morphometry have received recognition from the scientific community.

Impact and Influence

Dr. Badshah’s influence extends beyond research publications to shaping the next generation of medical and pharmaceutical scientists. His teaching philosophy emphasizes critical thinking, active participation, and evidence-based learning. By integrating innovative methodologies and fostering a collaborative learning environment, he has left a lasting impression on his students across different institutions. His work in surface anatomy and pharmacological sciences contributes to both clinical education and translational research, making his influence both academic and practical.

Legacy and Future Contributions

As a researcher with interdisciplinary expertise, Dr. Badshah’s legacy lies in his ability to merge anatomy with pharmacology for improved clinical outcomes. His ongoing research into bladder and prostate physiology offers potential breakthroughs in addressing urological disorders. Looking ahead, he aims to expand his collaborations globally, secure independent research leadership, and explore translational aspects of his work that could lead to therapeutic innovations. His legacy will continue to inspire young researchers and contribute to the evolution of biomedical sciences.

Publication

Investigating the Pharmacological Impact of Atosiban, an Oxytocin Receptor Antagonist, on Bladder and Prostate Contractions Within Obese and Non-Obese Rats
Authors: Masroor Badshah, Jibriil Ibrahim, Nguok Su, Penny Whiley, Sarah M. Turpin-Nolan, Khaled A. Elnahriry, Ralf Middendorff, Michael Whittaker, Betty Exintaris
Journal: Biomedicines
Year: 2025

Age-Dependent Effects of Oxytocin and Oxytocin Receptor Antagonists on Bladder Contractions: Implications for the Treatment of Overactive Bladder Syndrome
Authors: Masroor Badshah, Jibriil Ibrahim, Nguok Su, Penny Whiley, Ralf Middendorff, Michael Whittaker, Betty Exintaris
Journal: Biomedicines
Year: 2024

The Effects of Age on Prostatic Responses to Oxytocin and the Effects of Antagonists
Authors: Masroor Badshah, Jibriil Ibrahim, Nguok Su, Penny Whiley, Michael Whittaker, Betty Exintaris
Journal: Biomedicines
Year: 2023

Type of Treatment Supporters in Successful Completion of Tuberculosis Treatment: A Retrospective Cohort Study in Pakistan
Authors: Sana Hussain, Jamshed Hasnain, Zareen Hussain, Masroor Badshah, Hafeez Siddique, Christina Fiske, April Pettit
Journal: The Open Infectious Diseases Journal
Year: 2018

Morphology of the Human Hard Palate: A Study on Dry Skulls
Authors: Masroor Badshah, Roger Soames, Muhammad Jaffar Khan, Jamshaid Hasnain
Journal: Italian Journal of Anatomy and Embryology
Year: 2018

Conclusion

Dr. Masroor Badshah exemplifies the qualities of a dedicated academic, skilled researcher, and inspiring mentor. His career trajectory reflects a balance of teaching, research, and clinical exposure, with a focus on advancing pharmacology and anatomical sciences. His publications, conference presentations, and mentoring of students have strengthened his academic influence, while his research contributions offer practical applications in medicine. With a strong foundation and a vision for global collaboration, Dr. Badshah’s journey positions him as a leading figure in biomedical and pharmaceutical research, making his recognition as a distinguished researcher both timely and well-deserved.

Shahbaz Khan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Book of Award

Dr. Shahbaz Khan | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Pharmacy Academy, Institute of Foreign Trade and Management University | India

Author Profile

Scopus

Orcid

Google Scholar

Early Academic Pursuits

Dr. Shahbaz Khan’s academic journey reflects a strong commitment to pharmaceutical sciences, beginning with foundational studies in pharmacy and advancing through specialized postgraduate training in pharmacology. His scholarly dedication culminated in a doctoral degree in pharmaceutical sciences, where his research explored the phytochemical and pharmacological activities of Betula alnoides bark extracts. These early academic achievements not only provided him with a robust understanding of pharmacological principles but also shaped his future research interests in neuropharmacology, neuroscience, and inflammation studies.

Professional Endeavors

Dr. Khan’s professional career spans diverse academic and administrative roles in reputed institutions. He has served as a faculty member in both assistant and associate professor capacities, mentoring students at undergraduate, postgraduate, and doctoral levels. Alongside his teaching and research responsibilities, he has contributed significantly to institutional development through administrative positions such as hostel warden. His teaching philosophy combines rigorous academic training with practical exposure, ensuring that his students are well-prepared for the pharmaceutical and healthcare industries.

Contributions and Research Focus

Dr. Khan’s research portfolio is extensive and multidisciplinary, with particular emphasis on neuropharmacology, phytochemistry, and inflammation-related pathologies. His studies delve into the therapeutic potential of medicinal plants, the development of advanced drug delivery systems, and the role of nutraceuticals in managing neurodegenerative and chronic diseases. His work also encompasses nanomedicine, regenerative medicine, and targeted therapies, leading to innovations in formulations and biomedical applications. By integrating modern pharmacological techniques with traditional medicinal knowledge, he has made meaningful contributions to both preclinical research and applied therapeutic strategies.

Accolades and Recognition

Dr. Khan has earned multiple national and international honors that recognize his academic excellence and research contributions. His achievements include prestigious travel grants for participating in global scientific programs organized by international brain research organizations, as well as awards for specialized training in molecular neuropharmacology. These recognitions underscore his role as a scholar of global repute and his ability to represent Indian pharmaceutical research on international platforms.

Impact and Influence

The impact of Dr. Khan’s work extends beyond his own research, influencing students, collaborators, and the broader scientific community. His publications in high-impact journals have contributed to advancing knowledge in pharmacology, medicinal chemistry, and biomedical sciences. His patents and innovations in pharmaceutical formulations highlight his ability to bridge the gap between laboratory research and practical healthcare solutions. Through book authorship and editorial contributions, he has also enriched the academic resources available to scholars worldwide.

Legacy and Future Contributions

Dr. Khan’s legacy lies in his ability to combine teaching, research, and innovation into a cohesive professional identity. His mentorship has guided many students toward successful careers in pharmacy and research. Looking ahead, he aims to expand his research in neurotherapeutics, nanomedicine, and herbal pharmacology, with a focus on developing novel, safe, and effective treatments for neurological and inflammatory disorders. His future contributions are expected to further strengthen the role of pharmaceutical sciences in addressing global health challenges.

Publications

Exploring Betula alnoides Bark: Insilico and Preclinical Insights into its Antioxidant and Lipid-Lowering Effects in Hypercholesterolemia
Authors: Shahbaz Khan, Alka Lohani, Prashant Tiwari, Sunil Kumar Kadiri
Journal: Obesity Medicine
Year: 2025

Innovative nanomedicine for fungal infections: Advancing treatments through nanotechnology and mycological approaches
Authors: Alka Lohani, Ritika Saxena, Shahbaz Khan, Ana Figueiras, Filipa Mascarenhas-Melo
Journal: Journal of Drug Delivery Science and Technology
Year: 2025

Tailored polymeric hydrogels for regenerative medicine and drug delivery: From material design to clinical applications
Authors: Alka Lohani, Ritika Saxena, Joana Galvão Duarte, Shahbaz Khan, Ana Figueiras, Filipa Mascarenhas-Melo
Journal: International Journal of Pharmaceutics
Year: 2025

pH-responsive IPN beads of carboxymethyl konjac glucomannan and sodium carboxymethyl cellulose as a controlled release carrier for ibuprofen
Authors: Alka Lohani, Ritika Saxena, Shahbaz Khan, Filipa Mascarenhas-Melo
Journal: International Journal of Biological Macromolecules
Year: 2024

An Insight Into Neuropathic Pain: A Systemic and Up-To-Date Review
Authors: Himanshu Sharma, Tanzeeb Rani, Shahbaz Khan
Journal: International Journal of Pharmaceutical Sciences and Research
Year: 2023

Conclusion

Through unwavering dedication to research, teaching, and innovation, Dr. Shahbaz Khan has established himself as a respected authority in pharmaceutical sciences. His contributions continue to inspire students, peers, and the scientific community at large, ensuring his place as a pivotal contributor to advancements in healthcare and pharmacology.

 

Nehal Rami | Agricultural and Biological Sciences | Best Researcher Award

Published on by Book of Award

Dr. Nehal Rami | Agricultural and Biological Sciences | Best Researcher Award

Ganpat University | India

Author Profile

Scopus

Orcid

Google Scholar

🎓 Early Academic Pursuits

Dr. Nehal Rami embarked on his academic journey with a strong foundation in the life sciences. He earned his Bachelor's degree in Biotechnology, followed by a Master's in Bioinformatics, and culminated his scholarly path with a Ph.D. in Biotechnology. His educational background reflects a harmonious blend of biological insight and computational skill, empowering him to explore diverse domains such as genomics, structural biology, and molecular informatics.

👨‍🏫 Professional Endeavors

With over 17 years of academic experience, Dr. Rami has been a pillar of education and research at the Mehsana Urban Institute of Sciences, Ganpat University, serving as an Assistant Professor and Coordinator of the Microbiology Department. His role involves teaching, mentoring, curriculum development, and driving student engagement through innovative research projects.

🔬 Contributions and Research Focus

Dr. Rami's research contributions span a wide array of impactful areas. His projects include the creation of bioinformatics tools such as a DNA-to-protein conversion tool and IndiMicroExplorer, a database of Indian microbes. These initiatives showcase his passion for developing practical bioinformatics resources using tools like Perl, ASP, HTML, and Flash. He has extensively published review and research articles on topics like homology modeling, microarray technology, anticancer potential of medicinal plants, and biodegradable plastics from agricultural waste. His work on Annona squamosa L. for breast cancer and Trametes versicolor for health applications reflects his deep commitment to translational and sustainable biosciences.

🏆 Accolades and Recognition

Dr. Rami's research excellence has earned him numerous accolades:

➤ Secured 1st rank in an oral paper presentation on microarray technology at a national e-conference in 2020
➤ Mentored student teams that won Second and Third place in Shodh-GUNI Student Research Conventions in 2020 and 2018
➤ Published multiple Scopus-indexed articles and a book chapter on sustainable agriculture
➤ Guided more than 95 postgraduate students in biological sciences for their dissertations

These achievements underscore his dedication not only to research but also to student empowerment and academic mentorship.

🌍 Impact and Influence

Dr. Rami has left a lasting imprint on the biotechnology and bioinformatics landscape in Gujarat and beyond. His efforts in database development, natural product research, agro-biotechnology, and cancer biology have contributed significantly to the knowledge ecosystem. His interdisciplinary approach has bridged the gap between life sciences and computational biology, enabling practical applications in agriculture, health, and environmental sustainability.

🔮 Legacy and Future Contributions

Looking ahead, Dr. Nehal Rami is poised to further his research impact through major funded projects and innovative teaching methodologies. His recent submission of a ₹5 lakh Major Research Project to KCG exemplifies his ongoing commitment to advancing science and education. With a visionary approach to biotechnology and bioinformatics, Dr. Rami continues to inspire the next generation of researchers and educators.

Publications

📄Potential of Aegle marmelos (L.) Corrêa Extracts in the Management of Breast Cancer: Phytochemical Profiling and Molecular Docking Studies

  • Authors: Nehal Rami, Keyur Bhatt

  • Journal: Pharmacological Research - Natural Products

  • Year: 2025

📄Phytochemical Analysis and In Silico Pharmacological Profiling of Methanolic Extract from Annona squamosa L. Seeds for Breast Cancer

  • Authors: Nehal Rami, Bhushan Kulkarni, Sandesh Chibber

  • Journal: Educational Administration Theory and Practice Journal

  • Year: 2024

📄In vitro Antioxidant and Anticancer Potential of Annona squamosa L. Extracts Against Breast Cancer

  • Authors: Nehal Rami, Bhushan Kulkarni, Sandesh Chibber, Krupali Trivedi, Devendrasinh Jhala, Nilam Parmar

  • Journal: International Journal of Experimental Research and Review

  • Year: 2023

 

Hasnia Abdeldjebar | Chemistry | Best Research Article Award

Published on by Book of Award

Dr. Hasnia Abdeldjebar | Chemistry | Best Research Article Award

Scientific and Technical Research Centre in Physico-chemical Analysis (C.R.A.P.C) | Algeria

Author Profile

Scopus

Orcid

Google Scholar

📚 Early Academic Pursuits

Dr. Abdeldjebar’s academic journey began at the University of Science and Technology Houari Boumediene (USTHB) in Algiers, where she completed her Bachelor's, Master's, and Ph.D. in Medicinal Chemistry. Her Ph.D. research bridged theory and practice, investigating the reactivity of bioactive compounds and their interaction with biological targets — laying a solid foundation for her scientific career.

🧪 Professional Endeavors

Since 2019, she has served as a Permanent Researcher at CRAPC, Bou-Ismaïl, where she delves into quantum chemical simulations and material modeling. She applies a multifaceted approach involving DFT, IRC path tracking, docking simulations, and spectroscopy to study polymers, biomolecules, MOFs, and optoelectronic materials. Her research is deeply rooted in scientific precision and innovation.

🔬 Contributions and Research Focus

Dr. Abdeldjebar’s work revolves around:

🎯 Chemical Reactivity — including DFT analysis, Fukui functions, and NBO
⚙️ Reaction Mechanisms — modeling transition states and energy profiles
🧬 Medicinal Chemistry — using QSAR, docking, and ADMET predictions for drug design
⚗️ Nanomaterials & Polymers — studying structural-electronic relationships and stability
🔗 Organometallic Complexes — evaluating charge transfer and catalytic potential

Her ability to blend theoretical chemistry with computational and experimental tools has made significant contributions across chemistry, biophysics, and pharmaceutical science.

🏆 Accolades and Recognition

Dr. Abdeldjebar has authored numerous high-impact publications in journals such as New Journal of Chemistry, Superlattices and Microstructures, Journal of Molecular Structure, and Progress in Reaction Kinetics and Mechanism. Her contributions to SARS-CoV-2 inhibitor modeling and anti-cancer drug discovery have garnered international recognition. In 2025, she was appointed as a Reviewer for the Journal of Molecular Structure, reflecting her stature in the global research community.

🌍 Impact and Influence

Her research has impacted drug development, nanotechnology, and sustainable materials, with practical applications in healthcare, energy, and environmental science. Dr. Abdeldjebar has collaborated with scientists across Europe and Africa, pushing the boundaries of computational modeling and molecular innovation. Her contributions during the pandemic, especially on viral protease inhibition, exemplify science in service of humanity.

🌱 Legacy and Future Contributions

As she continues to bridge the worlds of chemistry, materials science, and biomedicine, Dr. Hasnia Abdeldjebar is poised to leave a lasting legacy. Her future work aims to explore AI-assisted molecular discovery, smart materials, and multi-target drug design, ensuring her contributions continue to benefit society, science, and education.

Publications

📄 Novel Small Molecule Derived from Hydroxy Naphthaldhyde as Potential Anti-Leukemia Agents: Spectroscopic, DFT, Docking Molecular and ADME/T Investigations
Authors: Chafia Ait Ramdane-Terbouche, Hasnia Abdeldjebar, Achour Terbouche, Houria Lakhdari, Khaled Ait Ramdane
Journal: Polycyclic Aromatic Compounds
Year: 2024

📄 Computational Docking Study of Calanolides as Potential Inhibitors of SARS-CoV-2 Main Protease
Author: Hasnia Abdeldjebar
Journal: French-Ukrainian Journal of Chemistry
Year: 2022

📄 Exploring Schiff Base Ligand Inhibitor for Cancer and Neurological Cells, Viruses and Bacteria Receptors by Homology Modeling and Molecular Docking
Author: Hasnia Abdeldjebar
Journal: Computational Toxicology
Year: 2022

📄 Crystal Structure, Hirshfeld Surface and Reactivity of Novel Ligand-L<sub>AT1</sub> Derived from Dehydroacetic Acid: Intermolecular Interactions with SARS-CoV-2/Main Protease
Author: Hasnia Abdeldjebar
Journal: Molecular Crystals and Liquid Crystals
Year: 2021

📄 Crystal Structure, Chemical Reactivity, Kinetic and Thermodynamic Studies of New Ligand Derived from 4-Hydroxycoumarin: Interaction with SARS-CoV-2
Author: Hasnia Abdeldjebar
Journal: Journal of Molecular Structure
Year: 2020

Yuanyuan Li | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Published on by Book of Award

Dr. Yuanyuan Li | Pharmacology, Toxicology and Pharmaceutical Science | Best Researcher Award

Guangdong Provincial Laboratory of Traditional Chinese Medicine | China

Author Profile

Scopus

🎓 Early Academic Pursuits

Dr. Li’s academic path began with an exceptional undergraduate performance in Chemistry at Jilin University. Her passion for science led her to pursue a Master’s degree in Analytical Chemistry and subsequently a Ph.D. in the same field, which she completed in July 2014 under the guidance of esteemed professor Zhang Shusheng. During her doctoral studies, she received comprehensive training in analytical techniques and developed a strong interest in practical applications related to food and environmental safety.

🏢 Professional Endeavors

In 2014, Dr. Li joined the School of Public Health at Jilin University as a faculty member. She steadily rose through the ranks to become a full professor and doctoral supervisor. Her responsibilities have included leading multiple high-level national projects, mentoring graduate students, and engaging in collaborative research across disciplines. She has become a pivotal figure in shaping the academic direction of the university’s public health research programs.

🔬 Contributions and Research Focus

Dr. Li’s research primarily focuses on food safety risk assessment, monitoring of toxic and hazardous substances in the food chain, and the development of advanced analytical methods. She has published over 80 high-impact academic papers, including articles in Analytical Chemistry, Biosensors and Bioelectronics, ACS Sensors, and TrAC Trends in Analytical Chemistry. Her work integrates innovative electrochemical and optical biosensing techniques, making significant advancements in the detection of pesticide residues, foodborne pathogens, and environmental pollutants.

🏆 Accolades and Recognition

Her excellence has not gone unnoticed. Dr. Li has received several prestigious honors, including the “Young Elite Scientists Sponsorship Program” by the China Association for Science and Technology and the First Prize for Scientific and Technological Progress by the Jilin Provincial Government. She has also served as a visiting scholar at the University of Michigan, where she broadened her international research collaboration network.

🌍 Impact and Influence

Dr. Li's research has had a profound impact on public health, food regulation, and environmental policy. Her cutting-edge methodologies contribute directly to national standards and have been implemented in real-world food safety monitoring. She is also an active member of professional organizations and frequently serves as a reviewer for top-tier scientific journals, thereby shaping the future of analytical science and public health on both national and global scales.

🔮 Legacy and Future Contributions

Looking forward, Dr. Yuanyuan Li is poised to continue her groundbreaking work in biosensor development and integrated health risk assessment. Her vision is to establish more comprehensive detection platforms that can safeguard food and environmental quality, ultimately enhancing public health resilience. As a mentor, researcher, and innovator, her legacy is one of rigorous science combined with a deep commitment to societal well-being.

 

Publications

📄 Shenxiong Yixin Decoction polysaccharides exert therapeutic effects against myocardial ischemia-reperfusion injury via intestinal exosomal microRNA-21 regulation

Authors:
De-Sheng Xu, Yan Wang, Zi-Rui Li, Ping-Li Mo, Ming-Tai Chen, Rui-Zhi Zhao, Zheng Fan, Wen-Jie Mo, Qi-Lu Li, Fang-Cao Pi, Qi-Di Sun, Juan-Min Li, Yun-Da Yao, Jian-Ping Chen, Yuan-Yuan Li, Jie-Nan Luan, Shang-Bin Zhang, Ying Xie, Hua Zhou

Journal: Pharmacological Research   Year: 2025

📄 Syringic acid attenuates acute lung injury by modulating macrophage polarization in LPS-induced mice

Authors:
W.-T. Wang, Y.-Y. Zhang, Z.-R. Li, J.-M. Li, H.-S. Deng, Y.-Y. Li, H.-Y. Yang, C.-C. Lau, Y.-J. Yao, H.-D. Pan, L. Liu, Y. Xie, H. Zhou et al.

Journal: Phytomedicine   Year: 2024

📄 A classical herbal formula alleviates high-fat diet induced nonalcoholic steatohepatitis (NASH) via targeting mitophagy to rehabilitate dysfunctional mitochondria, validated by UPLC-HRMS identification combined with in vivo experiment

Authors:
M.-T. Chen, F.R. Huang, B.-H. Chen, J.-L. Kang, Y.-J. Yao, M.-N. Liu, Y.-Y. Li, Y.-Q. Li, T.-R. Zhou, D.-T. Peng, L.-D. Luo, C.-S. Wei, Y.-F. Xing, Q.-B. Wu, H. Zhou, G.-D. Tong

Journal: Biomedicine & Pharmacotherapy   Year: 2023